The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 21, 2018
Filed:
Aug. 03, 2016
Applicants:
Ganymed Pharmaceuticals Ag, Mainz, DE;
Tron—translationale Onkologie an Der Universitätsmedizin Der Johannes Gutenberg-universität Mainz Ggmbh, Mainz, DE;
Inventors:
Ugur Sahin, Mainz, DE;
Ozlem Tureci, Mainz, DE;
Rita Mitnacht-Kraus, Friedberg, DE;
Stefan Woll, Nackenheim, DE;
Assignees:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); C07K 16/00 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); G01N 1/00 (2006.01); G01N 33/574 (2006.01); A61K 51/10 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); C07K 16/28 (2013.01); C07K 16/303 (2013.01); C07K 16/3023 (2013.01); C07K 16/3046 (2013.01); G01N 33/57492 (2013.01); C07K 2317/34 (2013.01); G01N 2800/52 (2013.01);
Abstract
The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.
Sahin, Ugur. (2018). Antibodies against claudin 18.2 useful in cancer diagnosis (U.S. Patent No. 10053512). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10053512
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile